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Abstract Impaired aortic distensibility index (ADI)
is associated with cardiovascular risk factors. This
study evaluates the relation of ADI measured by
computed tomographic angiography (CTA) with the
severity of coronary atherosclerosis in subjects with
suspected coronary artery disease (CAD). Two hun-
dred and twenty-nine subjects,age 63 ± 9 years, 42%
female, underwent coronary artery calcium (CAC)
scanning and CTA, and their ADI and Framingham
risk score (FRS) were measured. End-systolic and end-
diastolic (ED) cross-sectional-area(CSA) of ascend-
ing-aorta (AAo) was measured 15-mm above the left-
main coronary ostium. ADI was defined as: [(Dlumen-
CSA)/(lumen-CSA in ED 9 systemic-pulse-pres-
sure) 9 103]. ADI measured by 2D-trans-thoracic
echocardiography (TTE) was compared with CTA-
measured ADI in 26 subjects without CAC. CAC was
defined as 0, 1–100, 101–400 and 400?. CAD was
defined as luminal stenosis 0, 1–49% and 50%?. There
was an excellent correlation between CTA- and
TTE-measured ADI (r2 = 0.94, P = 0.0001). ADI
decreased from CAC 0 to CAC 400?; similarly from
FRS 1–9% to FRS 20% ? (P \ 0.05). After adjust-
ment for risk factors, the relative risk for each standard
deviation decrease in ADI was 1.66 for CAC 1–100,
2.26 for CAC 101–400 and 2.32 for CAC 400? as
compared to CAC 0; similarly, 2.36 for non-obstruc-
tive CAD and 2.67 for obstructive CAD as compared to
normal coronaries. The area under the ROC-curve to
predict significant CAD was 0.68 for FRS, 0.75 for
ADI, 0.81 for CAC and 0.86 for the combination (P\
0.05). Impaired aortic distensibility strongly correlates
with the severity of coronary atherosclerosis. Addition
of ADI to CAC and traditional risk factors provides
incremental value to predict at-risk individuals.
Keywords Aortic distensibility index  Computed
tomographic angiography  Coronary artery calcium
score  2D Trans-thoracic echocardiography
Introduction
Vascular dysfunction has been shown to be an
independent predictor of adverse cardiovascular
events [1–3]. Impaired vascular function is associated
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with coronary artery disease [4], hypertension [5],
diabetes [6, 7], and hypercholesterolemia [8–10].
Arterial distensibility, a measure of vascular
function, can serve as a marker of coronary heart
disease risk in humans [11, 12], In addition animal
studies suggest that reduced arterial distensibility is
an early sign of atherosclerotic change [13]. Previous
studies revealed an inverse relationship between
aortic distensibility and cardiovascular risk factors
and may predict outcome [14–16].
The aorta maintains low left ventricular after-load,
promotes optimal subendocardial coronary blood
flow [17], and transforms pulsatile into more luminar
blood flow. Impaired aortic distensibility leads to
higher left ventricular systolic pressures, diminished
subendocardial blood supply [17] and may ultimately
contribute to left ventricular dysfunction [18, 19].
Coronary artery calcium (CAC) is a marker of
overall atherosclerotic burden and correlates well
with the total plaque burden, the presence of
obstructive coronary artery disease (CAD) and future
cardiovascular events in both genders across ethnic-
ities [20–22]. Systemic vascular dysfunction mea-
sured through reactive hyperemia procedure is
strongly correlated with increasing Framingham risk
score (FRS) and CAC independent of age, sex, and
traditional cardiac risk factors and is superior to FRS
for the prediction of significant CAC [23].
This study evaluates whether impaired aortic dis-
tensibility index (ADI) is associated with the severity
of coronary atherosclerosis in at-risk individuals.
Methods
Subjects and study design
Two hundred and twenty-nine consecutive subjects
referred for coronary artery calcium (CAC) scanning
and CTA for suspected coronary artery disease
(CAD) were enrolled. Patients with established
cardiovascular disease, stroke, diabetic retinopathy,
Raynaud’s syndrome, infection, cancer, immunosup-
pression, systemic inflammation, advanced renal or
liver disease, creatinine [1.4 mg/dl, and triglyceride
[400 mg/dl were excluded. In a sub-study, 26
patients with normal coronaries and CAC 0 under-
went 2D trans-thoracic echocardiography (TTE). The
ascending aorta diameter and cross-sectional area
measured by CTA and TTE were compared. Risk
factors were determined, and FRS was calculated to
assess the risk of developing total coronary disease
events (angina, myocardial infarction, or cardiovas-
cular death) over the next 10 years [24].
CAC scanning
The coronary arteries were imaged with 30–40
contiguous 3 mm slices during mid-diastole using
ECG-triggering during a 15 s breath hold. CAC was
considered present in a coronary artery when a
density of [130 Hounsfield units (HU) was detected
in C3 contiguous pixels ([1 mm2) overlying that
coronary artery and quantified using the previously
described Agatston scoring method [25].
Cardiac CTA
Beta blockers were administered for pulses greater
than 65 bpm. CTA was performed according to
standard clinical technique with retrospective ECG
gating and ECG pulsing applied. Mean heart rate
during the scan was 57 ± 2 bpm.
Data acquisition
A 64- Multi-detector Computed Tomography (MDCT)
scanner (Lightspeed VCT, General Electric Healthcare
Technologies, Milwaukee, WI) was used for all
subjects. Imaging was started 1 inch above the left
main ostium and continued to 1 inch below the bottom
of the heart. The following imaging and reconstruction
parameters were applied: data acquisition collimation
0.625 mm 9 64 = 4 cm; 120 kVp; 220–670 mAs;
pitch 0.18–0.24 (depending on heart rate); rotation
time 0.35 s; slice width 0.625 mm; matrix 512 9 512
and pixel size 0.39 mm2. ECG-triggered dose modu-
lation was applied in each case with 400–600 mA in
60–80% R–R interval and 250–350 mA for the rest of
the cardiac cycle (81 to 59% of the next cycle).
Cardiac data were reconstructed from 5 to 95% of
R–R interval and with 10% intervals. Coronary vessels
were reviewed (AW Volume ShareTM, GE Medical
Systems, Milwaukee, WI) and volume renderings and
curved multi-planar reformations were done. CAC was
defined as CAC 0, CAC 1–100, CAC 101–400 and
CAC 400?. CAD was defined as normal coronaries,
non-obstructive and obstructive CAD (luminal
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stenosis 1–49 and 50%, respectively). Two skilled
cardiologists blinded to the clinical data measured the
CAC and interpreted CTA separately.
Measurements
Cardiac CTA
The principle of aortic distensibility measurement is
illustrated in Fig. 1. The window level and width of
300 and 800 HU was used. True CSA and diameter of
ascending aorta (AAo) was measured both manually
and with the automated software (Workstation AW
4.4, GE Medical Systems, Milwaukee, WI) using the
aligned and adjusted planes. The CSA and diameter
of AAo were measurements 15 mm above the ostium
of left main artery [26]. AAo diameter and CSA were
measured from 5 to 95% of the R–R interval in 10%
increments. Maximum AAo diameter and CSA was
observed at end-systolic phase, 35% of R–R interval
in individuals with a heart rate B60 bpm. AAo
diameter and CSA decreased linearly from end-
systole to end-diastole phases from 35 to 95% of R–R
interval; which the minimum AAo diameter and CSA
was observed at the end-diastolic (95% of R–R
interval) phase.
Consensus was reached with a third expert mea-
surement in case of disagreements between the
manual and automated measures (2 cases).
Fig. 1 Changes in the volume of ascending aorta (AAo) at the
end systolic and end diastolic phase, 35% and 95% of R–R
interval respectively, 15 mm above LM ostium using axial and
coronal views. Using axial image, AAo image 15 mm above
LM ostium was assessed (C), then perpendicular diameter and
volume of AAo was measured using coronal and oblique views
(B) at end systole and diastole, respectively
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ADI was defined as: [ADI = (D lumen AAo
CSA)/(end-diastole AAo CSA 9 systemic pulse
pressure) 9 103] [27, 28]. Dlumen AAo CSA is
defined as: end-systolic AAo CSA - end-diastolic
AAo CSA. Brachial artery blood pressure was
measured before and after CTA acquisition, and the
mean value was calculated.
Trans-thoracic echocardiography
In a sub-study, 26 subjects with normal coronaries
and CAC 0 underwent TTE within a week after
cardiac CTA. AAo diameter was measured 15 mm
above sinotubular junction in the M-mode tracings,
guided by the two-dimensional long parasternal axis
[29] using Hewlett-Packard Sonos 5,500 echocardio-
graphic system (Hewlett-Packard Corporation, Palo
Alto, CA). Simultaneous recording of the ECG
during TTE permitted evaluation of changes in
AAo diameter during various phases of cardiac cycle,
and reliable comparison with CTA measured AAo
diameter. AAo cross section area (CSA) was calcu-
lated from 35%, end-systolic-, and 95%, end-dia-
stolic-phase, of echocardiogram measured diameter
with the assumption that the CSA is circular
(area = (diameter/2)2 9 (p)). TTE and CTA mea-
sured ADI was driven from calculated and measured
AAo CSA, respectively.
Statistical analysis
Mean ± SD and proportions were used to summarize
the characteristics of the study group. Continuous
variables were compared by ANOVA, and categor-
ical variables were compared by the Kruskal–Wallis
multivariate analysis. Inter-observer and inter-modal-
ity (CTA vs. TTE) variability of AAo diameter
measurement were calculated using intra-class cor-
relation coefficient (ICC), and Bland & Altman plots
[30]. Relative risk regression analyses were
employed to assess the association between the
severity of CAC and ADI, also the association
between ADI and CAD before and after adjustment
for conventional cardiovascular risk factors, as well
as for Framingham risk score. ROC curves were
constructed and the area under the ROC curve (AUC)
was calculated to predict the ability of each model to
detect a) significant CAC (CAC 100?), and B)
significant CAD (obstructive CAD), respectively. All
statistical analyses were performed with PASW
version 18.0 (SPSS Institute Inc, Chicago, IL,
http://www.spss.com). The level of significance was
set at P \ 0.05 (two-tailed). The study protocol was
approved by the IRB Committee Board of the Los
Angeles Biomedical Research Institute at Harbor
UCLA, Torrance, California and all patients provided
written informed consent.
Results
Aortic distensibility index (ADI)
CTA measured ADI was compared to the TTE
measured ADI. There was excellent correlation
between CTA and TTE measured ADI (r2 = 0.94,
ICC = 0.99, P = 0.0001). However, CTA measured
ADI was 3.4% higher than TTE. (Figure 2a) There
was excellent inter-observer agreement in measuring
ADI using TTE and CTA. The inter-observer vari-
ability was higher with TTE than CTA (Fig. 2b).
Patient characteristics and aortic artery
distensibility
Patients were characterized based upon the severity of
CAC and placed into one of 4 groups (CAC 0, 1–100,
101–400 and 400?) (Table 1). There were no signif-
icant differences in gender, smoking status, diabetes
mellitus, hypertension, hypercholesterolemia, lipid
profile, and family history of premature CAD between
the cohorts. The mean age was higher in patients with
significant CAC as compared to normal cohort. The
Framingham risk score increased substantially with
increasing CAC. In a sub-study in subjects with CAC
zero, ADI decreased with the metabolic status from
normal cohorts to diabetes mellitus (P \ 0.05).
There was strong inverse correlation between ADI
and CAC (r2 = -0.69, P = 0.0001). ADI decreased
proportionally from CAC 0 to CAC 1–100 to CAC
101–400 to CAC 400? in both genders (Fig. 3a and
b). Furthermore, severity of CAC increased incre-
mentally in each FRS category as ADI decreased;
similarly, in each ADI category as FRS increased.
The highest CAC was noted with the combination of
the lowest tertile of ADI and FRS 20%?; The lowest
ADI was observed in subjects with highest CAC and
462 Int J Cardiovasc Imaging (2011) 27:459–469
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FRS (Fig. 3b). ADI decreased with the severity of
metabolic status in each CAC category in which
diabetics with CAC 400? had the least ADI.
(Figure 3c) After adjustment for age, gender, con-
ventional cardiac risk factors, and FRS by relative
risk regression analyses, the risk of each standard
deviation decrease in ADI was 1.66 for CAC 1–100,
2.26 for CAC 101–400 and 2.32 for CAC 400? as
compared to CAC 0. (Table 2) Multivariate regres-
sion analysis showed that ADI was an independent
predictor of the severity of CAC.
Increasing severity of CAD was associated with
increase in CAC and FRS, and decrease in ADI
(Table 1). After adjustment for age, gender, conven-
tional cardiac risk factors, and CAC, ADI was
independent predictor of significant CAD. (Table 3).
ROC curves were constructed to assess the ability
of cardiovascular risk factors and ADI to predict: a)
significant CAC, and b) significant CAD. The AUC
for proposed models is summarized in Fig. 4. Addi-
tion of ADI to FRS increased the area under the ROC
curve to predict significant CAC significantly from
0.63 to 0.84 (P \ 0.05) and provided the largest
contributor to significant CAC prediction. Similarly,
addition of ADI to CAC and traditional risk factors
increased the area under the ROC curve to predict
significant CAD from 0.68 to 0.86.
Discussion
The current study demonstrates that: 1. Excellent
correlation exists between TTE and CTA measured
ADI, 2- ADI decreased with the severity of metabolic
status, 3. CTA measured ADI decreased proportion-
ally with the severity of CAC independent of
cardiovascular risk factors, and 4. Addition of ADI
to FRS improved the ability to detect significant CAC
from 0.63 to 0.84.
There is considerable heterogeneity in the magni-
tude of vascular dysfunction in individuals with similar
risk factor profiles [31, 32]. In this regard, vascular
dysfunction may be seen as an important ‘‘integrative
factor’’ of the inherent atherosclerotic risk of an
individual which takes into account the cumulative
effects of various risk and protective factors [31]. In
addition to improving risk assessment for the predic-
tion of cardiovascular outcomes, another important
application of vascular function assessment is to
evaluate response to therapies [33–37].
Arterial distensibility serves as a marker of the
structure and function of the artery (i.e. vascular
function) and has been shown to diminish with
advancing age and with increasing cardiovascular
risk factors [38]. Recent studies have demonstrated
that oxidative modification of LDL particles, and
Variable (N=26) Ratio SDD 95 % CI  ICC P value 
CTA vs. TTE - AAo ADI 1.03 0.01 1.02 - 1.04 0.99 0.0001 
Inter-observer -TTE measured AAo ADI 1.011 0.008 0.99 - 1.19 0.98 0.0001 
Inter-observer -CTA measured AAo ADI 1.001 0.001   0.99 - 1.006 0.99 0.0001 
A B
Fig. 2 a The variability between TTE and CTA in measured aortic distensibility index. b CTA measured aortic artery distensibility
(ADI) correlated well with TTE measured ADI
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vascular wall remodeling induced by hyperglycemia
may play a pathophysiological role in reducing
arterial distensibility and revealed that aortic disten-
sibility decreased with increasing cardiovascular risk
factors [6, 8–10, 18, 19, 39].
Previous studies provided evidence that reduced
arterial distensibility predicts future cardiovascular
events [10, 15, 40]. Haluska et al. studied the
association of arterial distensibility and long-term
clinical outcome of 719 patients. They reported that
impaired arterial distensibility independently corre-
lated with poor outcome in patients with varying
degrees of cardiovascular risk, and arterial disten-
sibility can identify patients at risk of future fatal
and non-fatal events [41]. Finally, recent studies
have shown that functional changes in arteries
Table 1 Cardiovascular risk factors and the severity of coronary artery calcium
Coronary artery calcium Normal
(N = 78)
CAC 1–100
(N = 42)
CAC 101–400
(N = 40)
CAC 400?
(N = 69)
P value
Age (years) 55 ± 10 55 ± 9 57 ± 9 61 ± 8 0.001
Male gender 67% 61% 69% 68% 0.8
Smoking 0 0 3% 3% 0.4
Hypertension 46% 35% 57% 55% 0.2
High cholesterol 46% 41% 51% 38% 0.6
Diabetes mellitus§ 16% 19% 19% 15% 0.7
Family history of CHD|| 40% 43% 57% 58% 0.1
Statin therapy 7% 12% 25% 27% 0.1
BMI (kg/m2) 28.1 ± 3.6 28.8 ± 3.9 27.6 ± 5.1 28.4 ± 4.7 0.6
Total Cholesterol (md/dL) 191 ± 42 186 ± 37 171 ± 27 178 ± 43 0.7
HDL-C (mg/dL) 50 ± 10 46 ± 11 50 ± 14 46 ± 12 0.5
LDL-C (mg/dL) 116 ± 34 120 ± 26 100 ± 34 105 ± 39 0.4
Triglyceride (mg/dL) 112 ± 37 115 ± 28 96 ± 34 120 ± 32 0.2
SPB (mm Hg) 121 ± 11 129 ± 10 128 ± 15 132 ± 18 0.1
DBP (mm Hg) 75 ± 9 76 ± 8 76 ± 9 76 ± 9 0.9
Framingham risk score (%) 4.6 ± 2.6 5.2 ± 2.8 6.1 ± 3.3 8.9 ± 4.6 0.001
AAo 35% CSA (mm3) 49.71 ± 2.10 48.82 ± 1.77 47.02 ± 1.68 46.66 ± 1.75 0.08
AAo 95% CSA (mm3) 32.76 ± 1.91 33.34 ± 1.81 33.69 ± 1.69 34.14 ± 2.01 0.8
D AAo CSA/AAo 95% CSAX 0.57 ± 0.10 0.50 ± 0.07 0.39 ± 0.07 0.34 ± 0.06 0.003
ADID 10.7 ± 1.31 8.87 ± 1.13 7.29 ± 1.09 6.18 ± 0.92 0.003
CTA-Diagnosed coronary artery disease Normal
(N = 78)
CAD 1–29%
(N = 35)
CAD 30–49%
(N = 61)
CAD 70%
(N = 55)
P value
Framingham risk score (%) 4.6 ± 2.6 5.2 ± 2.5 7.4 ± 4.7 9.8 ± 5.7 0.001
Coronary artery calcium 0 43 ± 26 279 ± 115 385 ± 220 0.0001
ADID 10.7 ± 1.31 8.62 ± 1.19 7.26 ± 1.21 5.71 ± 1.21 0.0001
Values presented as mean ± SD or %
NS = Non-significant (P [ 0.05)
 Self-reported diagnosis of hypertension, prescribed medication for hypertension, or current blood pressure[140 mmHg systolic or
[90 mmHg diastolic ([130/80 mmHg if diabetic)
 Self-reported diagnosis of high cholesterol, prescribed medication for high cholesterol, or current total cholesterol [200 mg/dL
§ Self-reported diagnosis of diabetes (type 1 or 2) or prescribed medication for diabetes
|| First degree relative; female \ 65 yrs, male \ 55 years
X D AAo CSA = (AAo 35% CSA- AAo 95% CSA)/AAo 95% CSA
D ADI = (D AAo CSA/systemic pulse pressure) 9 103
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precede the development of structural changes and
also reverse more quickly in response to therapies
[37, 42–44].
Clinical guidelines recommend risk management
based on the Framingham score [45, 46] followed by
goal-directed therapy when necessary [47–49] in
Fig. 3 a Aortic distensibility index (ADI) decreased propor-
tionally with increasing the severity of coronary artery calcium
(CAC) in both genders. b ADI decreased with increasing CAC
and Framingham risk score, and c ADI decreased proportionally
with the severity of metabolic status
Table 2 Multivariate relative risk regression analysis of the relationship between the extent of coronary artery calcium and aortic
artery distensibility
Model Normal CAC 1–100 CAC 101–400 CAC 400?
Unadjusted
ADI¥ 1 (ref) 1.57 (1.28–1.93), P = 0.0001 2.18 (1.69–2.82), P = 0.0001 2.23 (1.78–2.78), P = 0.0001
Adjusted for age, gender, diabetes mellitus, hypertension, hypercholesterolemia, family history of CHD, and smoking status
ADI¥ 1 (ref) 1.66 (1.39–3.46), P = 0.0001 2.26 (1.73–3.28), P = 0.0001 2.32 (1.85–5.62), P = 0.0001
Relative risk for each standard deviation (SD) decrease in ADI (SD: 1.2)
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patients without known prior CAD. Recent studies
have showed that FRS has significant limitation in
identifying high risk subjects without known CAD
[50, 51]. Current findings revealed that CTA provides
an accurate measure for vascular function rather than
just anatomical studies; Furthermore, in this study
aortic distensibility decreased substantially with the
severity of coronary atherosclerosis in both genders.
The excellent correlations between impaired aortic
distensibility measured by CTA and FRS, and, in
particular, the superior independent and incremental
value of aortic distensibility for predicting significant
coronary atherosclerosis, highlight the role of
vascular function assessment as a part of cardiovas-
cular risk assessment to improve identification of
high risk individuals and optimizing patient
management.
Limitations
Beta blockers which are vasoactive medications were
administered for heart rates greater than 65 bpm.
However, recent studies demonstrated that concom-
itant therapy with non-nitrate vasoactive drugs has no
significant effect on vascular function assessment
Table 3 Multivariate relative risk regression analysis of the relationship between the severity of coronary artery diseases and aortic
artery distensibility
Model Normal Non-obstructive CAD Obstructive CAD
Unadjusted
ADI¥ 1 (ref) 2.29 (1.26–2.75), P = 0.0001 2.56 (1.94–3.36), P = 0.0001
Adjusted for age, gender, diabetes mellitus, hypertension, hypercholesterolemia, family history of CHD, smoking status and CAC
ADI¥ 1 (ref) 2.36 (1.35–3.15), P = 0.0001 2.67 (1.93–3.56), P = 0.0001
Relative risk for each standard deviation (SD) decrease in ADI (SD: 1.2)
£
 FRS: Framingham risk score – FRS: 1-9%, 10-20%, and 20%+ 
 
£
 FRS: Framingham risk score – FRS: 1-9%, 10-20%, and 20%+¥
 ADI: Aortic distensibility index – per each standard deviation decrease ¥
 ADI: Aortic distensibility index – per each standard deviation decrease 
  CAC: Coronary Artery Calcium- CAC: 0, 1-100, 101-400, and 400+
Variable AUC±SD 95% CI P Comparison P 
FRS£ 0.68 ± 0.04 0.59 - 0.78 0.0001 -- 
ADI¥ 0.75 ± 0.03 0.67 - 0.85 0.0001 0.001 
CAC 0.81 ± 0.02 0.79 – 0.90 0.0001 0.001 
FRS + ADI + CAC 0.86 ± 0.01 0.81– 0.92 0.0001 0.001 
Variable AUC±SD 95% CI P Comparison P 
FRS£ 0.63 ± 0.04 0.53 - 0.82 0.001 -- 
ADI¥ 0.74 ± 0.04 0.63 - 0.85 0.0001 0.01 
FRS + ADI 0.84 ± 0.03 0.74 – 0.91 0.0001 0.001 
Fig. 4 a ROC curves for 3 models created to assess the ability
of a combination of clinical variables to predict significant
coronary artery calcium (CAC 100?). b ROC curves for 4
models created to assess the ability of a combination of clinical
variables to predict significant coronary artery disease
466 Int J Cardiovasc Imaging (2011) 27:459–469
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[52]. The effect of data acquisition and analysis
during a breath-hold is another potential source of
error. Nonetheless, the CTA measurements correlated
well with the TTE measurements, suggesting that
potential errors introduced by non-simultaneous
blood pressures and breath-hold are minimal.
Conclusion
Aortic distensibility measured by CTA correlates
well with corresponding values measured by TTE.
Impaired aortic distensibility is associated with the
severity of coronary atherosclerosis independent of
age, gender, and cardiovascular risk factors. Further-
more, addition of ADI to traditional risk factors and
CAC provided the largest contribution to detect
significant coronary atherosclerosis, and highlights
the diagnostic utility of ADI in the early detection
and monitoring of patients with atherosclerotic car-
diovascular disease by a single noninvasive diagnos-
tic study.
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